Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Metabolic stress regulates ERK activity by controlling KSR-RAF heterodimerization

A. Verlande, M. Krafčíková, D. Potěšil, L. Trantírek, Z. Zdráhal, M. Elkalaf, J. Trnka, K. Souček, N. Rauch, J. Rauch, W. Kolch, S. Uldrijan,

. 2018 ; 19 (2) : 320-336. [pub] 20171220

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc19012967

Altered cell metabolism is a hallmark of cancer, and targeting specific metabolic nodes is considered an attractive strategy for cancer therapy. In this study, we evaluate the effects of metabolic stressors on the deregulated ERK pathway in melanoma cells bearing activating mutations of the NRAS or BRAF oncogenes. We report that metabolic stressors promote the dimerization of KSR proteins with CRAF in NRAS-mutant cells, and with oncogenic BRAF in BRAFV600E-mutant cells, thereby enhancing ERK pathway activation. Despite this similarity, the two genomic subtypes react differently when a higher level of metabolic stress is induced. In NRAS-mutant cells, the ERK pathway is even more stimulated, while it is strongly downregulated in BRAFV600E-mutant cells. We demonstrate that this is caused by the dissociation of mutant BRAF from KSR and is mediated by activated AMPK. Both types of ERK regulation nevertheless lead to cell cycle arrest. Besides studying the effects of the metabolic stressors on ERK pathway activity, we also present data suggesting that for efficient therapies of both genomic melanoma subtypes, specific metabolic targeting is necessary.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19012967
003      
CZ-PrNML
005      
20190411104814.0
007      
ta
008      
190405s2018 enk f 000 0|eng||
009      
AR
024    7_
$a 10.15252/embr.201744524 $2 doi
035    __
$a (PubMed)29263201
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Verlande, Amandine $u International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic. Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
245    10
$a Metabolic stress regulates ERK activity by controlling KSR-RAF heterodimerization / $c A. Verlande, M. Krafčíková, D. Potěšil, L. Trantírek, Z. Zdráhal, M. Elkalaf, J. Trnka, K. Souček, N. Rauch, J. Rauch, W. Kolch, S. Uldrijan,
520    9_
$a Altered cell metabolism is a hallmark of cancer, and targeting specific metabolic nodes is considered an attractive strategy for cancer therapy. In this study, we evaluate the effects of metabolic stressors on the deregulated ERK pathway in melanoma cells bearing activating mutations of the NRAS or BRAF oncogenes. We report that metabolic stressors promote the dimerization of KSR proteins with CRAF in NRAS-mutant cells, and with oncogenic BRAF in BRAFV600E-mutant cells, thereby enhancing ERK pathway activation. Despite this similarity, the two genomic subtypes react differently when a higher level of metabolic stress is induced. In NRAS-mutant cells, the ERK pathway is even more stimulated, while it is strongly downregulated in BRAFV600E-mutant cells. We demonstrate that this is caused by the dissociation of mutant BRAF from KSR and is mediated by activated AMPK. Both types of ERK regulation nevertheless lead to cell cycle arrest. Besides studying the effects of the metabolic stressors on ERK pathway activity, we also present data suggesting that for efficient therapies of both genomic melanoma subtypes, specific metabolic targeting is necessary.
650    _2
$a proteiny 14-3-3 $x chemie $x metabolismus $7 D048948
650    _2
$a kontrolní body buněčného cyklu $x genetika $7 D059447
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a aktivace enzymů $7 D004789
650    _2
$a extracelulárním signálem regulované MAP kinasy $x metabolismus $7 D048049
650    _2
$a GTP-fosfohydrolasy $x genetika $x metabolismus $7 D020558
650    _2
$a glukosa $x metabolismus $7 D005947
650    _2
$a glykolýza $7 D006019
650    _2
$a lidé $7 D006801
650    _2
$a melanom $x genetika $x metabolismus $7 D008545
650    _2
$a membránové proteiny $x genetika $x metabolismus $7 D008565
650    _2
$a mutace $7 D009154
650    _2
$a spotřeba kyslíku $7 D010101
650    _2
$a proteinkinasy $x chemie $x genetika $x metabolismus $7 D011494
650    12
$a multimerizace proteinu $7 D055503
650    _2
$a rekombinantní fúzní proteiny $7 D011993
650    12
$a fyziologický stres $7 D013312
650    _2
$a raf kinasy $x chemie $x genetika $x metabolismus $7 D048490
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Krafčíková, Michaela $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
700    1_
$a Potěšil, David $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
700    1_
$a Trantírek, Lukáš $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
700    1_
$a Zdráhal, Zbyněk $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
700    1_
$a Elkalaf, Moustafa $u Laboratory for Metabolism and Bioenergetics, Third Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Trnka, Jan $u Laboratory for Metabolism and Bioenergetics, Third Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Souček, Karel $u International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic. Laboratory of Cytokinetics, Institute of Biophysics, Academy of Sciences, Brno, Czech Republic. Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic.
700    1_
$a Rauch, Nora $u Systems Biology Ireland, University College Dublin, Dublin, Ireland. Conway Institute, University College Dublin, Dublin, Ireland. School of Medicine, University College Dublin, Dublin, Ireland.
700    1_
$a Rauch, Jens $u Systems Biology Ireland, University College Dublin, Dublin, Ireland. Conway Institute, University College Dublin, Dublin, Ireland. School of Medicine, University College Dublin, Dublin, Ireland.
700    1_
$a Kolch, Walter $u Systems Biology Ireland, University College Dublin, Dublin, Ireland. Conway Institute, University College Dublin, Dublin, Ireland. School of Medicine, University College Dublin, Dublin, Ireland.
700    1_
$a Uldrijan, Stjepan $u International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic uldrijan@med.muni.cz. Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
773    0_
$w MED00006590 $t EMBO reports $x 1469-3178 $g Roč. 19, č. 2 (2018), s. 320-336
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29263201 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190405 $b ABA008
991    __
$a 20190411104831 $b ABA008
999    __
$a ok $b bmc $g 1392277 $s 1051272
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 19 $c 2 $d 320-336 $e 20171220 $i 1469-3178 $m Embo reports $n EMBO Rep $x MED00006590
LZP    __
$a Pubmed-20190405

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace